Filed before 2025Filed 12 March 2020
Amunix Pharmaceuticals, Inc. raised $83.6M
Amunix Pharmaceuticals, Inc., a biotech company based in Mountain View, CA, raised $83.6M in a new equity round, according to a filing dated 12 March 2020.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 12 March 2020
- Round
- Equity round
- Amount sold
- $83.6M
- Offering size
- $83.6M
- Investors so far
- 21
- Based in
- Mountain View, CA
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
3 directors of this company are named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 93% of the 1,744 tracked raises with an amount filed in 2020, and than 84% of the 152 in biotech.
Amunix Pharmaceuticals, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 9 Mar 2021 | New filing | $117M | Another raise |
| 21 Jan 2021 | New filing | — | Another raise |
| 17 Jul 2020 | New filing | — | Another raise |
| 12 Mar 2020 | New filing | $83.6M | This raise |
More with Frazier Life Sciences on the board
- Enlaza Therapeutics, Inc.$15M
- Sudo Biosciences, Inc.$63.6M
- MBX Biosciences, Inc.$46.7M
- 98point6 Inc.$20.9M
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.